Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emixustat Hydrochloride for Geographic Atrophy in Dry Age-Related Macular Degeneration
2012-004952-12Phase 2Completed
- Sponsor
- Kubota Vision
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of emixustat in dry age-related macular degeneration, geographic atrophy (GA) and age-related macular degeneration (AMD) (3 arms), sponsored by Kubota Vision. Started Mar 2013; status: completed.
02
Drugs
emixustat
03
Conditions
dry age-related macular degenerationgeographic atrophy (GA)age-related macular degeneration (AMD)
Beyond the preview
Go deeper on 2012-004952-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004952-12.